Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Immune-modulation Improve the Survival in Patients With Severe Sepsis? "A Proof of the Concept Study"

NCT02025660 is registered in ClinicalTrials.gov with Post Graduate Institute of Medical Education and Research, Chandigarh as lead sponsor.

NCT NCT02025660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02025660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Immune-modulation Improve the Survival in Patients With Severe Sepsis? "A Proof of the Concept Study"
Lead sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2013
Completion date
March 31, 2014
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune modulation, septic shock, severe sepsis